am 251 has been researched along with Benign Neoplasms in 1 studies
AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paul, RK | 1 |
| Wnorowski, A | 1 |
| Gonzalez-Mariscal, I | 1 |
| Nayak, SK | 1 |
| Pajak, K | 1 |
| Moaddel, R | 1 |
| Indig, FE | 1 |
| Bernier, M | 1 |
| Wainer, IW | 1 |
1 other study available for am 251 and Benign Neoplasms
| Article | Year |
|---|---|
(R,R')-4'-methoxy-1-naphthylfenoterol targets GPR55-mediated ligand internalization and impairs cancer cell motility.
Topics: Cell Movement; Drug Inverse Agonism; Endocytosis; Fenoterol; HEK293 Cells; Hep G2 Cells; Humans; Lig | 2014 |